Meteorin-like/Meteorin-β Is a Novel Immunoregulatory Cytokine Associated with Inflammation

Irina Ushach1,2, Gerardo Arrevillaga-Boni1,2, Gina N Heller1,2

  • 1Department of Physiology and Biophysics, University of California, Irvine, Irvine, CA 92697.

Insights

We discovered Meteorin-like (Metrnl), a novel cytokine produced by macrophages and barrier tissues. Metrnl plays a key role in regulating immune responses and controlling inflammation.

Area of Science:

  • Immunology
  • Molecular Biology

Background:

  • Meteorin-like (Metrnl) is a novel cytokine secreted by activated macrophages and barrier tissues.
  • Its production is regulated by various pro-inflammatory and anti-inflammatory cytokines, as well as LPS.
  • Metrnl levels in circulation correlate with in vivo inflammatory responses.

Purpose of the Study:

  • To characterize the novel cytokine Meteorin-like (Metrnl) and its role in immune regulation.
  • To investigate the function of Metrnl in vivo using a Metrnl knockout mouse model.

Main Methods:

  • Gene expression analysis of Metrnl in macrophages and barrier tissues.
  • Generation and phenotypic analysis of Metrnl knockout mice.
  • Assessment of cytokine production, IgG levels, and sepsis susceptibility in Metrnl knockout mice.

Main Results:

  • Metrnl is a secreted protein (∼28 kDa) produced by macrophages and barrier tissues.
  • Metrnl knockout mice exhibit dysregulated cytokine production, altered IgG levels, and increased susceptibility to LPS-induced sepsis.
  • Older Metrnl knockout mice develop inflammatory lesions, indicating a role in controlling inflammation.

Conclusions:

  • Metrnl is a novel immunoregulatory cytokine involved in controlling inflammatory responses.
  • Metrnl plays a significant role in maintaining immune homeostasis and preventing excessive inflammation.

Related Concept Videos

Inflammation01:38

Inflammation

Overview
62.1K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.5K
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
3.8K
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
1.6K
Antihypertensive Drugs: Types of β-Blockers01:28

Antihypertensive Drugs: Types of β-Blockers

β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and...
1.7K
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
919